- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BI 655064 dose 2
Total 1262 results
-
Boehringer IngelheimCompletedLupus NephritisSpain, United Kingdom, United States, Canada, Thailand, Germany, Italy, Japan, Serbia, Australia, Korea, Republic of, Mexico, Malaysia, Philippines, Poland, Portugal, Greece, Hong Kong, Czechia, France
-
AbbVieBoehringer IngelheimCompletedPsoriasisUnited States, Germany, United Kingdom
-
Boehringer IngelheimCompletedHealthyKorea, Republic of
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHealthy | Arthritis, RheumatoidGermany, Netherlands, New Zealand, Poland, Spain, Czechia
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimTerminatedPurpura, Thrombocytopenic, IdiopathicUnited States
-
AbbVieNo longer availableCrohn's Disease | Ulcerative Colitis (UC)
-
Boehringer IngelheimCompletedSchizophreniaSpain, Korea, Republic of, United Kingdom, Taiwan, United States, Austria, Italy, Germany, Poland, Japan, Canada
-
Boehringer IngelheimCompletedAlzheimer DiseaseSpain, United Kingdom, Italy, United States, Canada, Germany, Greece, Austria, Norway, France, Japan, Hungary, Poland, Finland
-
Boehringer IngelheimCompletedLupus NephritisUnited Kingdom, Thailand, Germany, Japan, United States, Australia, Korea, Republic of, Hong Kong, Poland, Greece, Mexico, Czechia, Canada, Malaysia, Philippines, Portugal
-
AbbVieCompletedPsoriasisUnited States, Australia, Austria, Belgium, Canada, Czechia, Finland, France, Germany, Japan, Korea, Republic of, Mexico, Poland, Portugal, Spain, Sweden, Taiwan
-
AbbVieCompletedA Study to Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic DermatitisDermatitisUnited States, Australia, Canada, Japan, Puerto Rico
-
AbbVieCompleted
-
Boehringer IngelheimCompletedHealthyJapan, Korea, Republic of
-
Edgewise Therapeutics, Inc.RecruitingDuchenne Muscular DystrophyUnited States
-
Edgewise Therapeutics, Inc.RecruitingDuchenne Muscular DystrophyUnited States
-
Boehringer IngelheimCompleted
-
AbbVieBoehringer IngelheimCompleted
-
AbbVieBoehringer IngelheimCompleted
-
AbbVieActive, not recruitingPsoriatic Arthritis (PsA)United States, Argentina, Australia, Belgium, Brazil, Canada, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Singapore, South Africa, Spain, Sweden, United...
-
AbbVieCompletedPsoriasisUnited States, Canada, France, Germany, Italy, Netherlands, Poland, Spain, United Kingdom
-
Institute of Medical Biology, Chinese Academy of...Guangxi Center for Disease Control and PreventionCompleted
-
AbbVieCompletedRisankizumab Therapy Versus Placebo for Subjects With Psoriasis in the Russian Federation (IMMPRESS)PsoriasisRussian Federation
-
AbbVieBoehringer IngelheimCompletedAsthmaUnited States, Korea, Republic of, Belgium, Taiwan, Canada, Germany, United Kingdom, France, Netherlands, Poland
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Colombia, Croatia, Czech Republic, Denmark, Estonia, France, Georgia, Greece, Hong Kong, Hungary, India, Indonesia, Israel, Italy, Japan, Korea, Republic of, Malaysia and more
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveGermany
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Germany
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
AbbVieCompleted
-
Boehringer IngelheimCompleted
-
AbbVieActive, not recruitingPsoriatic ArthritisUnited States, Argentina, Australia, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Chile, Croatia, Czechia, Denmark, Estonia, Finland, Germany, Greece, Israel, Italy, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico and more
-
Presidio Pharmaceuticals, Inc.Boehringer IngelheimCompletedChronic Hepatitis CUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Denmark, France, Ireland, Korea, Republic of, Portugal, United Kingdom
-
Boehringer IngelheimCompletedHepatitis C, ChronicFrance, Germany, Switzerland
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Brazil, Bulgaria, Canada, Colombia, Denmark, Estonia, Hungary, Italy, Lebanon, Malaysia, Mexico, Peru, Philippines, Poland, Romania, Russian Federation, Spain, Sweden, Taiwan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, China, France, Germany, India, Korea, Republic of, Mexico, Slovakia, Slovenia, Taiwan, Turkey
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Rutgers, The State University of New JerseyCenters for Disease Control and PreventionCompletedViolence | Helping Behavior | Sexual Assault and Rape | Assaultive BehaviorUnited States
-
Bial - Portela C S.A.CompletedPulmonary Arterial Hypertension | Cardiovascular Disease+Pulmonary DiseaseUnited Kingdom
-
Boehringer IngelheimCompletedPsoriasisUnited States, Canada, Finland, France, Germany, Norway, Sweden
-
University of MinnesotaRecruitingSolid Organ TransplantUnited States